Selvita Team Grows to Over 250 People
News Aug 11, 2015
Selvita has been intensively expanding its operations. The total employment at Selvita increased to 261 people, including 86 PhDs in August.
The period of 2014-2015 marks a significant increase for Selvita in terms of revenue and operations, both in its drug discovery outsourcing segment as well in the internal pipeline.
The company has recently signed several large and long-term services contracts in the area of medicinal and analytical chemistry with some of the most renowned pharma companies.
Selvita has also been successively expanding its capabilities in terms of proteomics, which has effected in establishing new collaborations also in this area.
The employment has been increasing accordingly, from 173 people in 2013, to 230 at the end of 2014.
Selvita is continuously investing in new laboratory infrastructure and highly qualified scientific staff, aiming to provide best quality integrated drug discovery services to pharmaceutical and biotechnology companies.
New Partnership to Provide Bioanalytical and DMPK ServicesNews
Concept Life Sciences, the integrated drug discovery, development and analytical services company, and Alderley Analytical, bioanalytical Contract Research Organisation (CRO), today announced they have signed a partnership agreement to provide high-value bioanalytical and DMPK study services.
Toothpaste Ingredient Could Help Fight Drug-Resistant MalariaNews
An ingredient commonly found in toothpaste could be employed as an anti-malarial drug against strains of malaria parasite that have grown resistant to one of the currently-used drugs.READ MORE
Small Compound Able to Stave Tumor and Stop its GrowthNews
Researchers at Vanderbilt University Medical Center (VUMC) have demonstrated for the first time that it is possible to starve a tumor and stop its growth with a newly discovered small compound that blocks uptake of the vital nutrient glutamine.READ MORE